This has been explained a few times already. This is a supply...

This has been explained a few times already. This is a supply agreement relating to Amgen's Omnipod/Neulasta drug device combo that neutropenic patients take. This was a combo product that was launched in 2015. The five year supply contract, started in 2013, is being rolled over. By all accounts this product is doing very very well in the market.

The wearable market is not an all or nothing game. There will be drugs that will need patients or doctors to pre-fill WI's, as done in this case.

Unilife has many things to worry about but this is not one of them. As JR has said at the AGM, everybody's telling him his product is the best in town....

https://www.neulasta.com/~/media/am.../pdf/responsive/onpro-technical-brochure.ashx